Evgen Pharma plc announced a private placement for the gross proceeds of $17,400,000 on January 16, 2024. The transaction included participation from new investor Stalicla SA.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 GBX | 0.00% | -2.86% | -46.88% |
05-28 | EARNINGS AND TRADING: Victorian Plumbing profit up; Xeros loss narrows | AN |
05-28 | Theracryf Appoints Susan Foden As Chair | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.88% | 4.59M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- EVG Stock
- News Theracryf Plc
- Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA